Centre for Respiratory Infection Research.
In plain English
AI plain-English summaryA single London campus will pool its leading researchers on flu, common colds, and tuberculosis into a dedicated centre for respiratory infections. Respiratory infections kill millions globally each year, yet effective vaccines and treatments remain elusive for many of them. The problem is that research on these diseases is often fragmented, with molecular biologists, immunologists, and clinicians working in separate silos. This centre aims to break down those walls by providing stable core funding for interdisciplinary work, allowing scientists to move seamlessly from fundamental studies of how the immune system responds to infection through to testing new therapies in human volunteers. If the centre succeeds, it could accelerate the development of new vaccines and antiviral drugs for influenza and tuberculosis, and potentially for bacterial respiratory infections that the team plans to expand into. More broadly, the centre’s structure is designed to give the UK a permanent, rapid-response capability for future respiratory outbreaks—a system that can pivot quickly when a new pathogen emerges, rather than scrambling to assemble expertise from scratch.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Strategic Award - SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know